Successful ‘East Meets West’ meeting in Suzhou, China

7461
7466
7463
7462
7464
7465
Unique meeting provided a comprehensive comparison of European and Chinese current practices and policies in the management of osteoporosis, osteoarthritis and sarcopenia.

On October 17, 2018, IOF participated at the ‘East meets West’ meeting, a unique forum held to review current practices and policies in the management of musculoskeletal ageing. Osteoporosis, osteoarthritis and sarcopenia - serious and costly disorders of the musculoskeletal system - were the key focus of presentations by leading European and Chinese experts. The lectures and discussions provided a comprehensive comparison of European and Chinese guidance and management strategies in the three disease areas.

‘East meets West’ took place at the start of the 9th International Conference on Osteoporosis and Bone Research 2018 (ICOBR2018) in Suzhou, China, and was organized by the Chinese Medical Association (CMA), the Chinese Society of Osteoporosis and Bone Mineral Research (CSOBMR), and the European Society for Clinical and Economic Aspects of Osteoporosis Osteoarthritis and Musculoskeletal Diseases (ESCEO).

After an introduction by ESCEO President Jean-Yves Reginster and CSOBMR President Weibo Xia, Dr John Beard, WHO, set the scene for the Meeting with his opening presentation on musculoskeletal health and aging from the WHO perspective. European speakers also included IOF President Cyrus Cooper, IOF Honorary President John Kanis, ESCEO Scientific Advisor Board Chair Professor René Rizzoli, and Etienne Cavalier (President Royal Belgian Society of Laboratory Medicine, ESCEO SAB and IOF CSA member).

The speakers highlighted European guidance, policies and perspectives regarding central issues such as fracture risk assessment; use of biochemical markers in osteoporosis; clinical guidance for osteoporosis management; ESCEO algorithm for the assessment of osteoarthritis; safety of paracetamol and non-steroidal anti-inflammatory drugs in osteoarthritis; use of calcium and vitamin D; and sarcopenia management. Leading speakers from China addressed similar issues from a Chinese perspective.

Professor Reginster stated:

This was a very fruitful forum for discussion which has given us important strategic insights to help inform healthcare priorities as we move forward to address the increasing burden of musculoskeletal diseases in our ageing populations. Our intention is to develop a consensus statement which reflects discussions at the meeting and sets the scene for further clinical guidance.”

Professor Cyrus Cooper concluded:

The immense and growing burden of musculoskeletal diseases in the ageing population is a topic of concern to health care authorities worldwide. This was reflected in the high-level of interest for this meeting, which was endorsed by the National Health Commission of the People’s Republic of China, the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, the Belgian Senate, and the Belgian Federal Ministry of Health and Social Affairs.

View meeting programme